Statistics for Edgewise Therapeutics, (id:8001 EWTX)
Valuation metrics
Market cap
2.98B
Enterprise value
2.49B
Trailing P/E (ttm)
-20.51
Forward P/E
-16.99
PEG ratio
-16.99
Price/Sales (ttm)
Price/Book (mrq)
6.07
Enterprise Value/Revenue
Enterprise Value/EBITDA
-17.14
Overview
Shares outstanding
94.69M
Float
54.37M
Shares short
7.29M
% Held by insiders
0.00%
% Held by institutions
1.11%
Average volume (10 days)
845.28K
Average volume (90 days)
Price summary
52-Week low
5.93
52-Week high
38.12
52-Week change
80.71%
Beta
0.15
50-Day moving average
29.52
200-Day moving average
20.87
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-22.36%
Return on equity
-31.90%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-145,179,008.00
Net income to common (ttm)
-124,294,000.00
Diluted EPS (ttm)
-1.50
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
492.54M
Total cash per share (mrq)
5.20
Total debt (mrq)
4.44M
Total Debt/Equity (mrq)
0.91
Current ratio (mrq)
2.63K%
Book value per share (mrq)
5.18
Cash flow
Cash flow statement
-108,901,000.00
Levered free cash flow (LFCF)
-64,966,248.00